Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06120452 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation
A NA study, sponsored by Rael.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06120452 is a NA study that has completed, run by Rael. The registered enrollment target is 40 participants.
The verdict
NCT06120452, a NA study, has completed, sponsored by Rael.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of the Rael Miracle Clear Complete Acne Serum product in improving facial acne and post-acne pigmentation. This study will last for 56 days. The study will be conducted as a single-arm trial where all participants will use the test products. Participants will be required to complete questionnaires at Baseline, Day 1, Day 3, Day 7, Day 14, Day 28, and Day 56. Photos will be taken at Baseline, Day 28, and Day 56. The photos from Baseline and Day 56 will undergo expert skin grading
Interventions
- OTHER Rael Miracle Clear Complete Acne Serum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06120452
The ClinicalTrials.gov registry entry for NCT06120452 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rael, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rael Miracle Clear Complete Acne Serum is the first listed.
NCT06120452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06120452 about?
NCT06120452 is a clinical study titled "A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation". This study will evaluate the efficacy of the Rael Miracle Clear Complete Acne Serum product in improving facial acne and post-acne pigmentation. This study will last for 56 days. The study will be conducted as a single-arm trial where all participants will use the test products. Participants will be...
What is the current status of trial NCT06120452?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-10-06. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT06120452?
The interventions under investigation include: Rael Miracle Clear Complete Acne Serum (OTHER).
Who is sponsoring clinical trial NCT06120452?
This trial is sponsored by Rael, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.